Umbilical cord levels of interleukin-1 receptor antagonist and neonatal outcome

Biology of the Neonate

Volumn 89, Issue 4, 2006, Pages 220-226

  Elsmén, Emma ^a   Ley, David ^a   Cilio, Corrado M ^a   Hansen Pupp, Ingrid ^a   Hellström Westas, Lena ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bronchopulmonary dysplasia; Interleukin 1 receptor antagonist; Morbidity; Outcome; Preterm

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

APGAR SCORE; AREA UNDER THE CURVE; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; ENCEPHALOMALACIA; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; INTUBATION; LUNG DYSPLASIA; MALE; NEWBORN; NEWBORN ASSESSMENT; NEWBORN DEATH; NEWBORN MORBIDITY; NEWBORN PERIOD; PREMATURITY; PRIORITY JOURNAL; PUERPERAL DEPRESSION; RECEIVER OPERATING CHARACTERISTIC; ROC CURVE; SEX DIFFERENCE; SURVIVAL RATE; UMBILICAL CORD;

FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; PREGNANCY; PREGNANCY OUTCOME; ROC CURVE; SEX CHARACTERISTICS; SIALOGLYCOPROTEINS; UMBILICAL CORD;

EID: 33745099230     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089838     Document Type: Article

References (25)

1. Elsmén E, Hansen-Pupp I, Hellström-Westas L: Preterm male infants need more initial respiratory and circulatory support than female infants. Acta Paediatr 2004;93:529-533.
2. Yoon BH, Jun JK, Romero R, Park KH, Gomez R, Choi JH, et al: Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997;177:19-26.
3. Romero R, Gomez R, Galasso M, Mazor M, Berry SM, Quintero RA, et al: The natural interleukin-1 receptor antagonist in the fetal, maternal, and amniotic fluid compartments: The effect of gestational age, fetal gender, and intrauterine infection. Am J Obstet Gynecol 1994;171:912-921.
4. Kalish RB, Vardhana S, Gupta M, Chasen ST, Perni SC, Witkin SS: Interleukin-1 receptor antagonist gene polymorphism and multifetal pregnancy outcome. Am J Obstet Gynecol 2003;189:911-914.
5. Bry K, Teramo K, Lappalainen U, Waffarn F, Hallman M: Interleukin-1 receptor antagonist in the fetomaternal compartment. Acta Paediatr 1995;84:233-236.
6. Lecart C, Cayabyab R, Buckley S, Morrison J, Kwong KY, Warburton D, et al: Bioactive transforming growth factor-beta in the lungs of extremely low birthweight neonates predicts the need for home oxygen supplementation. Biol Neonate 2000;77:217-223.
7. Van Marter LJ, Leviton A, Kuban KC, Pagano M, Allred EN: Maternal glucocorticoid therapy and reduced risk of bronchopulmonary dysplasia. Pediatrics 1990;86:331-336.
8. Fischer E, Marano MA, Van Zee KT, Rock CS, Hawes AS, Thompson WA, et al: Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest 1992;89:1551-1557.
9. Cai Z, Pang Y, Lin S, Rhodes PG: Differential roles of tumor necrosis factor-alpha and interleukin-1 beta in lipopolysaccharide-induced brain injury in the neonatal rat. Brain Res 2003;975:37-47.
10. Edelson MB, Bagwell CE, Rozycki HJ: Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 1999;103(4Pt 1):766-771.
11. Lynch EA, Dinarello CA, Cannon JG: Gender differences in IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist secretion from mononuclear cells and urinary excretion. J Immunol 1994;153:300-306.
12. Bry K, Lappalainen U, Waffarn F, Teramo K, Hallman M: Influence of fetal gender on the concentration of interleukin-1 receptor antagonist in amniotic fluid and in newborn urine. Pediatr Res 1994;35:130-134.
13. Geiger R, Ellemunter H, Fink FM, Falk M, Tilg H: Circulating interleukin-1 receptor antagonist levels in neonates. Eur J Pediatr 1996;155:811-814.
14. Papile L, Burstein L, Burstein R, Koffler H: Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birthweight less than 1,500 g. J Pediatr 1978;92:529-534.
15. Yanowitz TD, Jordan JA, Gilmour CH, Towbin R, Bowen A, Roberts JM, et al: Hemodynamic disturbances in premature infants born after chorioamnionitis: association with cord blood cytokine concentrations. Pediatr Res 2002;51:310-316.
16. Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR: Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N Engl J Med 2000;343:378-384.
17. Piecuch RE, Leonard CH, Cooper BA, Sehring SA: Outcome of extremely low birth weight infants (500 to 999 grams) over a 12-year period. Pediatrics 1997;100:633-639.
18. Hindmarsh GJ, O'Callaghan MJ, Mohay HA, Rogers YM: Gender differences in cognitive abilities at 2 years in ELBW infants. Extremely low birth weight. Early Hum Dev 2000;60:115-122.
19. Hoffman EL, Bennett FC: Birth weight less than 800 grams: changing outcomes and influences of gender and gestation number. Pediatrics 1990;86:27-34.
20. Vallette JD Jr, Goldberg RN, Suguihara C, Del Moral T, Martinez O, Lin J, et al: Effect of an interleukin-1 receptor antagonist on the hemodynamic manifestations of group B streptococcal sepsis. Pediatr Res 1995;38:704-708.
21. Hata T, Kawamura T, Inada K, Fujiwaki R, Hata K, Kitao M: Interleukin-1 receptor antagonist in cord blood: effects of labor and fetal distress. Gynecol Obstet Invest 1996;42:21-23.
22. Kuster H, Weiss M, Willeitner AE, Detlefsen S, Jeremias I, Zbojan J, et al: Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet 1998;352:1271-1277.
23. Kakkera DK, Siddiq MM, Parton LA: Interleukin-1 balance in the lungs of preterm infants who develop bronchopulmonary dysplasia. Bio Neonate 2005;87:82-90.
24. Speer CP: Pre- and postnatal inflammatory mechanisms in chronic lung disease of preterm infants. Paediatr Respir Rev 2004;5(suppl A):S241-S244.
25. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 1991;77:1627-1652.